KERREY J ROBERT 4

What Happened

• Kerrey J. Robert, a director of Tenet Healthcare Corp. (THC), sold a total of 5,638 shares on May 28, 2026, across multiple transactions. The sales reported on the Form 4 totaled approximately $983,920 in gross proceeds.
• Reported individual transactions: 1,969 shares at $173.12 ($340,873); 1,690 shares at $173.97 ($294,009); 713 shares at $175.13 ($124,868); 905 shares at $176.89 ($160,085); and 361 shares at $177.52 ($64,085). All transactions are reported as sales (S).

Key Details

• Transaction date: May 28, 2026; Form 4 filed May 29, 2026 (appears timely).
• Prices shown are weighted average sale prices for each aggregate block; reported price ranges for those blocks were:
  • F1 (1,969 sh): $172.63–$173.60
  • F2 (1,690 sh): $173.69–$174.37
  • F3 (713 sh): $174.92–$175.69
  • F4 (905 sh): $176.21–$177.20
  • F5 (361 sh): $177.25–$178.08
• Shares owned after the transaction: not specified in the information provided.
• Transaction type: sales (open-market/private sale as reported). No indication in the provided text of a 10b5-1 plan, option exercise, gift, or tax-withholding event.

Context

• These are outright sales by a company director. Sales do not necessarily indicate negative views—insiders sell stock for many reasons (liquidity, diversification, taxes)—and Form 4 reports are factual disclosures only.
• For retail investors, purchases are often viewed as stronger signals than routine sales; this filing documents insider selling activity totaling roughly $984K on a single day.